EPM2A Antikörper
-
- Target Alle EPM2A Antikörper anzeigen
- EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EPM2A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität (Details)
- Expected species reactivity: Mouse, Rat, Dog, Cow
- Aufreinigung
- Antigen affinity
- Immunogen
- Amino acids EATGHTNEMKHTTD were used as the immunogen for this Laforin antibody. This sequence is common to isoform a only.
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product EPM2A Primärantikörper
-
-
- Applikationshinweise
-
Optimal dilution of the Laforin antibody should be determined by the researcher.
1. This Laforin antibody is specific for isoform a.\. Western blot: 0.1-0.3 μg/mL,Immunohistochemistry (FFPE): 3-6 μg/mL,ELISA (peptide) LOD: 1:16000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- 0.5 mg/mL in 1X TBS, pH 7.3, with 0.5 % BSA (US sourced) and 0.02 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store the Laforin antibody at -20°C.
-
- Target
- EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))
- Andere Bezeichnung
- Laforin (EPM2A Produkte)
- Synonyme
- TG-B antikoerper, Tg(TcraK,TcrbK)TG-BFlv antikoerper, EPM2 antikoerper, MELF antikoerper, laforin antikoerper, EPM2A, laforin glucan phosphatase antikoerper, epilepsy, progressive myoclonic epilepsy, type 2 gene alpha antikoerper, EPM2A antikoerper, Epm2a antikoerper
- Hintergrund
- Additional name(s) for this target protein: EPM2A, EPM2A
- Gen-ID
- 7957
- Pathways
- Cellular Glucan Metabolic Process
-